Comments on:

FDA approves GE brain imaging tool for Alzheimer's

Back to the article » |
WASHINGTON (AP) — The Food and Drug Administration on Friday approved a radioactive imaging chemical from General Electric to help screen patients for Alzheimer's disease and dementia. The drug, Vizamyl, is an injection of radioactive material designed to highlight abnormal brain plaque in medical imaging scans. Dementia caused by Alzheimer's is associated with buildup of the plaque, known as...

To learn more about commenting on and our community guidelines, please see our comments FAQ.